Hahn Mark W (CIK 1408502) reported 22 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-18). Recent activity: Sell SLNO (10,046 shares), Buy SLNO (10,046 shares), Sell VRNA (11.3M shares), Buy VRNA (3.3M shares), Sell VRNA (3.3M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | SOLENO THERAPEUTICS INC (SLNO) | Director | Sell | 10,046 | $0 |
| 2025-10-14 | SOLENO THERAPEUTICS INC (SLNO) | Director | Buy | 10,046 | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 11.3M | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Chief Financial Officer | Buy | 3.3M | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 3.3M | $0 |
| 2025-09-03 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 1.2M | $0 |
| 2025-08-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | Buy | 255,696 | $0 |
| 2025-08-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 208,912 | $2.7M |
| 2025-07-09 | Verona Pharma plc (VRNA) | Chief Financial Officer | Buy | 229,512 | $0 |
| 2025-07-09 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 90,320 | $1.0M |
| 2025-06-13 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 400,000 | $4.6M |
| 2025-05-29 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 162,704 | $1.5M |
| 2025-05-29 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 32,432 | $309,077 |
| 2025-05-29 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 204,864 | $1.9M |
| 2025-05-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 108,272 | $969,034 |
| 2025-05-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | Buy | 200,000 | $0 |
| 2025-05-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 78,736 | $704,687 |
| 2025-05-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 400,000 | $3.6M |
| 2025-05-01 | Verona Pharma plc (VRNA) | Chief Financial Officer | Buy | 229,512 | $0 |
| 2025-05-01 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 90,360 | $811,433 |
| 2025-02-04 | Verona Pharma plc (VRNA) | Chief Financial Officer | Buy | 200,000 | $0 |
| 2025-02-04 | Verona Pharma plc (VRNA) | Chief Financial Officer | Sell | 166,888 | $1.2M |
Source: SEC Form 4 filings · as of 2026-05-18